Abstract
Located at the level of brain capillaries, the blood–brain barrier (BBB) is a crucial component of the neurovascular unit, since its highly regulated properties are needed to maintain optimal conditions for proper neuronal and glial functions. By modelling the BBB it is possible to make predictions about whether a compound’s interaction with the BBB is likely to compromise its functionality. A dysfunctional BBB may either affect brain entry of an agent or indirectly generate unwanted effects on neurons and glial cells by disturbing the brain homeostasis.
Since the BBB controls the exchanges between the blood and brain compartments modelling the BBB in vitro can also help to investigate the ability of compounds to cross the BBB. In this chapter, the plethora of in vitro BBB models that exist today is discussed and several methods needed to set up and use of these in vitro models in the framework of in vitro toxicity study is detailed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, Leybaert L, Molnar Z, O’Donnell ME, Povlishock JT, Saunders NR, Sharp F, Stanimirovic D, Watts RJ, Drewes LR (2011) Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 12(3):169–182
Zhang B, Chen L, Choi JJ, Hennig B, Toborek M (2012) Cerebrovascular toxicity of PCB153 is enhanced by binding to silica nanoparticles. J Neuroimmune Pharmacol 7(4):991–1001
Chen L, Zhang B, Toborek M (2012) Autophagy is involved in nanoalumina-induced cerebrovascular toxicity. Nanomedicine 9(2):212–221
Eyal S, Hsiao P, Unadkat JD (2009) Drug interactions at the blood–brain barrier: fact or fantasy? Pharmacol Ther 123(1):80–104
Cecchelli R, Berezowski V, Lundquist S, Culot M, Renftel M, Dehouck MP, Fenart L (2007) Modelling of the blood–brain barrier in drug discovery and development. Nat Rev Drug Discov 6(8):650–661
Prieto P, Blaauboer BJ, de Boer AG, Boveri M, Cecchelli R, Clemedson C, Coecke S, Forsby A, Galla HJ, Garberg P, Greenwood J, Price A, Tahti H (2004) Blood–brain barrier in vitro models and their application in toxicology. The report and recommendations of ECVAM workshop 49. Altern Lab Anim 32(1):37–50
Deli MA, Abraham CS, Kataoka Y, Niwa M (2005) Permeability studies on in vitro blood–brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25(1):59–127
Weksler BB, Subileau EA, Perriere N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO (2005) Blood–brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19(13):1872–1874
Urich E, Lazic SE, Molnos J, Wells I, Freskgard PO (2012) Transcriptional profiling of human brain endothelial cells reveals key properties crucial for predictive in vitro blood–brain barrier models. PLoS One 7(5):e38149
Meresse S, Dehouck MP, Delorme P, Bensaid M, Tauber JP, Delbart C, Fruchart JC, Cecchelli R (1989) Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. J Neurochem 53(5):1363–1371
Abbott J, Rönnbäck L, Hansson HA (2006) Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7:41–53
Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood–brain barrier integrity during embryogenesis. Nature 468(7323):562–566
Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A, Palecek SP, Shusta EV (2012) Derivation of blood–brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol 30(8):783–791
Toth A, Veszelka S, Nakagawa S, Niwa M, Deli MA (2011) Patented in vitro blood–brain barrier models in CNS drug discovery. Recent Pat CNS Drug Discov 6(2):107–118
DeBault LE, Cancilla PA (1980) gamma-Glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells in vitro. Science 207(4431):653–655
Dehouck MP, Meresse S, Delorme P, Fruchart JC, Cecchelli R (1990) An easier, reproducible, and mass-production method to study the blood–brain barrier in vitro. J Neurochem 54(5):1798–1801
Boveri M, Berezowski V, Price A, Slupek S, Lenfant AM, Benaud C, Hartung T, Cecchelli R, Prieto P, Dehouck MP (2005) Induction of blood–brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line. Glia 51(3):187–198
Cecchelli R, Dehouck B, Descamps L, Fenart L, Buee-Scherrer VV, Duhem C, Lundquist S, Rentfel M, Torpier G, Dehouck MP (1999) In vitro model for evaluating drug transport across the blood–brain barrier. Adv Drug Deliv Rev 36(2–3):165–178
Lundquist S, Renftel M, Brillault J, Fenart L, Cecchelli R, Dehouck MP (2002) Prediction of drug transport through the blood–brain barrier in vivo: a comparison between two in vitro cell models. Pharm Res 19(7):976–981
Culot M, Lundquist S, Vanuxeem D, Nion S, Landry C, Delplace Y, Dehouck MP, Berezowski V, Fenart L, Cecchelli R (2008) An in vitro blood–brain barrier model for high throughput (HTS) toxicological screening. Toxicol In Vitro 22(3):799–811
Vandenhaute E, Sevin E, Hallier-Vanuxeem D, Dehouck MP, Cecchelli R (2011) Case study: adapting in vitro blood–brain barrier models for use in early-stage drug discovery. Drug Discov Today 17(7–8):285–290
Dore-Duffy P (2008) Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des 14(16):1581–1593
Vandenhaute E, Dehouck L, Boucau MC, Sevin E, Uzbekov R, Tardivel M, Gosselet F, Fenart L, Cecchelli R, Dehouck MP (2011) Modelling the neurovascular unit and the blood–brain barrier with the unique function of pericytes. Curr Neurovasc Res 8(4):258–269
Booher J, Sensenbrenner M (1972) Growth and cultivation of dissociated neurons and glial cells from embryonic chick, rat and human brain in flask cultures. Neurobiology 2(3):97–105
Bornstein MB (1958) Reconstituted rat tail collagen used as substrate for time tissue cultures on coverslips in Maximow slides and roller tubes. Lab Invest 7:134–139
Hammarlund-Udenaes M, Friden M, Syvanen S, Gupta A (2008) On the rate and extent of drug delivery to the brain. Pharm Res 25(8):1737–1750
Franke H, Galla HJ, Beuckmann CT (1999) An improved low-permeability in vitro-model of the blood–brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res 818(1):65–71
Hallier-Vanuxeem D, Prieto P, Culot M, Diallo H, Landry C, Tahti H, Cecchelli R (2009) New strategy for alerting central nervous system toxicity: integration of blood–brain barrier toxicity and permeability in neurotoxicity assessment. Toxicol In Vitro 23(3):447–453
Fabulas-da Costa A, Aijjou R, Hachani J, Landry C, Cecchelli R, Culot M (2013) In vitro blood–brain barrier model adapted to repeated-dose toxicological screening. Toxicol In Vitro 27(6):1944–1953
Hammarlund-Udenaes M (2000) The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics. Adv Drug Deliv Rev 45(2–3):283–294
Kalvass JC, Maurer TS (2002) Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery. Biopharm Drug Dispos 23(8):327–338
Friden M, Gupta A, Antonsson M, Bredberg U, Hammarlund-Udenaes M (2007) In vitro methods for estimating unbound drug concentrations in the brain interstitial and intracellular fluids. Drug Metab Dispos 35(9):1711–1719
Kalvass JC, Maurer TS, Pollack GM (2007) Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios. Drug Metab Dispos 35(4):660–666
Culot M, Fabulas - da Costa A, Sevin E, Szorath E, Martinsson S et al (2013) A Simple Method for Assessing Free Brain/Free Plasma Ratios Using an In Vitro Model of the Blood Brain Barrier. PLoS ONE 8(12):e80634. doi:10.1371/journal.pone.0080634
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Fabulas-Da Costa, A. et al. (2014). Blood–Brain Barrier In Vitro Models and Their Applications in Toxicology. In: Bal-Price, A., Jennings, P. (eds) In Vitro Toxicology Systems. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0521-8_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0521-8_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0520-1
Online ISBN: 978-1-4939-0521-8
eBook Packages: Springer Protocols